Sen. Eliz­a­beth War­ren urges FTC to 'scru­ti­nize' two phar­ma buy­outs

Sen. Eliz­a­beth War­ren (D-MA) is call­ing on se­nior Fed­er­al Trade Com­mis­sion of­fi­cials to “close­ly scru­ti­nize” two pro­posed phar­ma merg­ers.

War­ren ex­pressed con­cern over “ram­pant con­sol­i­da­tion in the phar­ma­ceu­ti­cal in­dus­try,” in par­tic­u­lar Am­gen’s $28 bil­lion plans to take over Hori­zon Ther­a­peu­tics, and In­di­v­ior’s pro­posed ac­qui­si­tion of Opi­ant for $145 mil­lion up­front, in a let­ter to FTC Chair Lina Khan and Com­mis­sion­ers Al­varo Bedoya and Re­bec­ca Kel­ly Slaugh­ter ear­li­er this week.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER